Showing results (231-240 of 281) with videos related to
Sort By:
Pageof 29
Psychiatry Research|September 20, 2020
Childhood maltreatment and impact on clinical features of major depression in adultsGustavo C Medeiros, William L Prueitt, Abu Minhajuddin, et al.Cancer|March 17, 2006
Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experienceFariba Navid, Victor M Santana, Catherine A Billups, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Protracted intermittent schedule of topotecan in children with refractory acute leukemia: a pediatric oncology group studyWayne L Furman, Clinton F Stewart, Mark Kirstein, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1991
Therapeutic effects and pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in childhood cancer patients receiving myelosuppressive chemotherapyW L Furman, D L Fairclough, R D Huhn, et al.Leukemia|January 1, 1993
Clinical significance of CD10 expression in childhood acute lymphoblastic leukemiaC H Pui, G K Rivera, M L Hancock, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Phase I study of everolimus in pediatric patients with refractory solid tumorsMaryam Fouladi, Fred Laningham, Jianrong Wu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1994
11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemiaC H Pui, F G Behm, J R Downing, et al.Journal of Pain and Symptom Management|April 24, 2010
Factors that distinguish symptoms of most concern to parents from other symptoms of dying childrenMichele Pritchard, Elizabeth A Burghen, Jami S Gattuso, et al.Journal of Pain and Symptom Management|October 14, 2009
Bereaved parents' perceptions about when their child's cancer-related death would occurMichele Pritchard, Deo Kumar Srivastava, James O Okuma, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
UGT1A1 promoter genotype correlates with SN-38 pharmacokinetics, but not severe toxicity in patients receiving low-dose irinotecanClinton F Stewart, John C Panetta, Melinda A O'Shaughnessy, et al.Pageof 29